Blood Pressure Management

Redefining Hypertension Therapy in 2036: Precision, Permanence,and Prevention

by Prateek Chopra | June 5, 2026 | Cardiology Conferences | ESH 2026 Emerging Paradigm: Hypertension affects ~1.3 billion people worldwide, yet fewer than 25% achieve adequate BP control. Poor medication adherence, especially with polypharmacy, remains a critical barrier. This review explores whether hypertension therapy requires reinvention and evaluates emerging pharmacological, device-based, and AI-driven strategies poised to transform care by 2036. […]

Renal Denervation for Resistant Hypertension in CKD and ESRD: ESH 2026 Clinical Update

by Prateek Chopra | June 4, 2026 | Cardiology Conferences | ESH 2026 Clinical Rationale: Renal denervation (RDN) is being evaluated as an adjunctive therapy for patients with advanced CKD, end-stage renal disease (ESRD), and resistant hypertension. Current evidence is drawn from ESH/ESC recommendations, sham-controlled randomized trials, registries, observational studies, and ongoing clinical protocols. Current Recommendations: Key Evidence: Emerging Applications: Renal

Renal Denervation for Resistant Hypertension in CKD and ESRD: ESH 2026 Clinical Update Read Post »

Leave a Comment / ESH Day 1 / bluetree.healthcare@gmail.com / July 29, 2026 / Blood Pressure Management, Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD), Renal Denervation (RDN), Resistant Hypertension